Increased dietary potassium and magnesium attenuate experimental volume dependent hypertension possibly through endogenous sodium-potassium pump inhibitor

Clinical and Experimental Hypertension

Volumn 25, Issue 2, 2003, Pages 103-115

  Pamnani, Motilal B ^a   Bryant, Howard J ^a   Clough, David L ^a   Schooley, James F ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Dietary magnesium; Dietary potassium; Hypertension; Na+ K+ pump inhibitor; Na+ K+ ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); MAGNESIUM; POTASSIUM; SODIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIET; ENZYME ACTIVITY; ENZYME MECHANISM; FLUID INTAKE; HEART MUSCLE CELL; HYPERTENSION; MALE; NONHUMAN; POTASSIUM EXCRETION; POTASSIUM INTAKE; RAT; SODIUM EXCRETION; URINARY EXCRETION;

ANIMALS; BLOOD PRESSURE; CARDENOLIDES; DIGOXIN; DISEASE MODELS, ANIMAL; HYPERTENSION; KIDNEY; MAGNESIUM; MALE; MYOCARDIUM; NA(+)-K(+)-EXCHANGING ATPASE; ORGAN SIZE; POTASSIUM, DIETARY; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; REGRESSION ANALYSIS; SAPONINS;

EID: 0037326119     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-120017931     Document Type: Article

References (47)

1. Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, Simons-Morton DG, Conlin PR, Svetkey LP, Erlinger TP, Moore TJ, Karanja N. Effects of diet and sodium intake on blood pressure; subgroup analysis of the DASH-sodium trial. Ann Intern Med 2001; 135:1019-1028.
2. Frisancho AR, Leonard WR, Bolletins L. Blood pressure in blacks and whites and its relationship to sodium and potassium intake. J Chronic Dis 1984; 37:515-519.
3. Coruzzi P, Brambilla L, Gualerzi M, Rossi M, Parati G, Di Rienzo M, Tadonio J, Novarini A. Potassium depletion and salt sensitivity in hypertension. J Clin Endocrinol. 2001; 86:2857-2862.
4. Grim CE, Luft F, Miller JZ, Meenley GR, Battaebee HD, Hames CG, Dahl LK. Racial differences in blood pressure in Evans County Georgia: relation to sodium and potassium intake and plasma renin activity. J Chronic Dis. 1980; 33:87-94.
5. Langford HC. Dietary sodium, potassium and calcium in black hypertensives subjects. J. Clin Hypertens. 1987; 3(3):36S-42S.
6. Ford ES. Race, education, dietary cations: findings from the Third National Health and Nutrition Examination Survey. Eth Dis 1998; 1:10-20.
7. Langford HG, Watson RL. Potassium and calcium intake, excretion, and homeostasis in blacks and their relation to blood pressure: Cardiovascular Drugs and Therapy 1990; 4(2):403-406.
8. Matlou SM, Isles CG, Higgs A, Milne FJ, Murray GD, Schultz E, Stark IF. Potassium supplementation in blacks with mild to moderate essential hypertension. J Hypertens 1986; 4:61-64.
9. Tobian L. Dietary sodium chloride and potassium have effects on the pathophysiology of hypertension in humans and animals. Am J Cli Nutr 1997; 65:605S-611S.
10. Morris RC, Sebastian A, Forman A, Tanaka M, Schmidlin O. Normotensive salt sensitivity: effects of race and dietary potassium. Hypertension 1999; 33:18-33.
11. Fotherby MD, Patter JF. Potassium supplementation reduces clinic and ambulatory blood pressure in elderly hypertensive patients. J Hypertens. 1992; 10:1403-1408.
12. Hu G, Tian H. A comparison of dietary and non-dietary factors of hypertension and normal blood pressure in a Chinese population. J Hum Hypertens 2001; 15:487-493.
13. Meneely GR, Ball COT. Experimental epidemiology of chronic sodium chloride toxicity and the protective effect of potassium chloride. Am J Medicine 1958; 25:713-725.
14. Meneely GR, Lemley-Stone J, Darby WJ. Changes in blood pressure and body sodium of rats fed sodium and potassium chloride. Am J Cardiology 1961; 8:527-532.
15. Battarbee HD, Funch DP, Dailey JW: The effect of dietary sodium and potassium upon blood pressure and catecholamine excretion in the rat. Proc Soc Exp Biol Med 1979; 161:32-37.
16. Tobian L: Salt and hypertension. Hypertension 1992; 17(I):152-158.
17. Witteman JC., Grobbee DE., Derkx FH, Bouillon R, de Bruijn AM, Hoffman A. Reduction of blood pressure in women with mild to moderate hypertension. Am J Clin Nutr 1994; 60:129-135.
18. Geleijnse JM, Wittman JC, Back AA, den Breeijen JH, Grobbee DE. Reduction in blood pressure with a low sodium, high potassium salt in older subjects with mild to moderate hypertension. BMJ 1994; 309:436-440.
19. Van Leer EM, Seidell JC, Kromhout D. Dietary calcium, magnesium and blood pressure in Netherlands. Int J Epidemiol 1995; 24:1117-1123.
20. Laurant P, Hayoz D, Bruner HR, Berthelot A. Effect of magnesium deficiency on blood pressure and mechanical properties of rat carotid artery. Hypertension 1999; 33:1105-1110.
21. Laurant P, Kantelip JP, Berthelot A. Dietary magnesium supplementation modifies blood pressure and cardiovascular function in mineralocarticoid-salt hypertension rats but not in normotensive rats. J Nut 1995; 125:830-841.
22. Purvis JR, Cummings DM, Landsman P, Carrol R, Barakat H, Bray J, Whitley C, Horner RD. Effect of oral magnesium supplementation on selected cardiovascular risk factors in non-insulin dependent diabetes. Arch Fam Med 1994; 503-508.
23. Barri YM, Wingo CS. The effects of potassium depletion and supplementation on blood pressure: a clinical review. Am J Med Sci 1997; 314:37-40.
24. Chen WT, Brace RA, Scott JB, Anderson DK, Handy FA. The mechanism of vasodilator action of potassium. Proc Soc Exp Biol Med 1972; 140:820-824.
25. Cress LW, Areas W, Handy F, Muldoon S. Effects of buffalin on norepinephrine turnover in canine saphenous vein. Hypertension 1991; 18:516-522.
26. Sealey JE, Clark I, Bull MB, Laragh JH. Potassium balance and the control of renin release. J Cli Invest 1970; 49:2119-2127.
27. Linas SL. The mechanism of hyperreninemia in the potassium depleted rat. J Clin Invest 1981; 68:347-355.
28. +-ATPase in centrally mediated hypotensive effects of potassium in anesthetized rats. J Hypertens 1991; 9:167-170.
29. Shah J, Jandhyala BS. Antagonism by endothelin of centrally mediated cardiovascular effects of potassium in anesthetized rats. Clin Expt Pharmacol Physiol 1992; 19:89-94.
30. Altura BM, Altura BT. New perspectives on the role of magnesium in the pathophysiology of cardiovascular system. II. Experimental aspects. Magnesium 1985; 4:245-271.
31. Classen HG. Systemic stress, magnesium status and cardiovascular damage. Magnesium 1986; 5:105-110.
32. Pamnani MB, Chen X, Handy FA, Schooley JF, Mo Z. Mechanism of antihypertensive effect of dietary potassium in experimental volume expanded hypertension in rats. Clin Exp Hypertens 2000; 22:555-569.
33. Chen S, Yuan C, Clough D, Schooley J, Handy FA, Pamnani MB. Role of digitalis-like substance in the hypertension of the streptozotocin-induced diabetes in reduced renal mass rats. Am J Hypertens 1993; 6:397-406.
34. + pump in some models of experimental hypertension. Am J Nephrol 1983; 3:92-99.
35. + pump inhibitor in essential hypertension and in normotensive subjects following acute volume expansion. Am J Hypertens 1989; 2:524-531.
36. Pamnani MB, Whitehorn W, Clough D, Handy FA. Effect of canrenone in rats with reduced renal mass saline hypertension. Am J Hypertens 1990; 3:188-195.
37. +)-ATPase associated with essential hypertension. Nature 1982; 300:1-3.
38. Nakagawa H, Shimamoto K, Nakayowa M, Limura O. The role of endogenous digitalis-like factor in hypertensive mechanism in reduced renal mass hypertensive rats. Nippon Naibunpi Gakkai Zasshi 1993; 69:562-574.
39. Hollenberg NK, Graves SW. Endogenous sodium pump inhibition: current status and therapeutic opportunities. Prog Drug Res 1996; 46:9-42.
40. Hamlyn JM, Blaustein MP, Bova S, Du Charme DW, Harris DW, Mandel F, Matthews WR, Ludens JH. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci USA 1991; 88:6259-6263.
41. Kolbel F, Schreiber V. The endogenous digitalis-like factor. Mol Cell Biochem 1996; 160-161:111-115.
42. Langford HG. Sodium potassium interaction in hypertension and hypertensive cardiovascular disease. Hypertension 1991; 17(I):155-157.
43. Singh H, Linas SL. Potassium therapy of hypertension. Miner Electrolyte Metabol 1993; 19:57-63.
44. Pamnani MB, Harder DR, Huot SH, Bryant HJ, Kutyna FA, Handy FA. Vascular smooth muscle membrane potential and a ouabain like humoral factor in one-kidney, one clip hypertension in rats. Clin Sci 1982; 63:31s-33s.
45. Blaustein MP. Sodium ions, calcium ions, blood pressure regulation and hypertension: a reassessment and a hypothesis. Am J Physiol 1977; 232:C165-C173.
46. Luft FC, Miller JZ, Grim CE, Fineberg NS, Christian JC, Gaugherty SA, Weinberger MH. Salt sensitivity and resistance of blood pressure. Age and race factors in physiological responses. Hypertension 1991; 17(I):I102-I108.
47. Suter PM. Potassium and hypertension. Nutr Rev 1998; 56:151-153.